Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company on 07/09/2024, with an aggregate market value of $109,777.31. The shares were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with a cash payment made on the same date. This planned transaction follows a series of sales over the past three months, where a total of 78,124 shares were sold for gross proceeds of $645,887.34.

Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company on 07/09/2024, with an aggregate market value of $109,777.31. The shares were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with a cash payment made on the same date. This planned transaction follows a series of sales over the past three months, where a total of 78,124 shares were sold for gross proceeds of $645,887.34.